DAEWOONG CO.,LTD

(주)대웅 · KOSPI: 003090 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name: (주)대웅
Market / ticker: KOSPI · 003090
Industry: Pharmaceuticals and medicinal chemicals
Established: 1961-01-10
Fiscal year ends: December
Website: www.daewoong.com/
DART corp code: 00111810
Latest revenue: ₩2.07T (FY2025)

Items worth checking

medium

Litigation filed or ruled — filed 2026-09-02.

Source: Litigation filed

low

Guarantee or collateral provided for another party — filed 2026-09-04.

Source: Decision to guarantee debt of another party

Financial summary

KRW	FY2023	FY2024	FY2025
Revenue	₩1.81T	₩1.94T	₩2.07T
Operating income	₩195.6B	₩281.9B	₩261.8B
Net income	₩191.4B	₩68.9B	₩227.9B
Total assets	₩2.36T	₩2.72T	₩3.23T
Total liabilities	₩922.5B	₩1.22T	₩1.46T
Total equity	₩1.44T	₩1.50T	₩1.77T
Share capital	₩29.1B	₩29.1B	₩29.1B

Consolidated statements · FY2025 operating margin 12.7% · liabilities to equity 83% · Annual report FY2025 (Korean original)

Auditor opinions

Period	Auditor	Opinion
Term 66 (current)	한영회계법인	Unqualified
Term 65 (prior)	삼정회계법인	Unqualified
Term 64 (two years prior)	삼정회계법인	Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

Date	Filing	Original
2026-09-04	Decision to guarantee debt of another party	DART
2026-09-02	Litigation filed	DART
2026-08-14	Half-year report (2026.06)	DART
2026-07-10	Material management matter	DART
2026-06-30	Amended: New facility investment	DART
2026-06-26	Single sales / supply contract signed	DART
2026-06-23	Material management matter	DART
2026-06-01	Corporate governance report	DART
2026-05-26	Material management matter	DART
2026-05-26	Material management matter	DART
2026-05-21	Material management matter	DART
2026-05-20	Amended: Material management matter	DART
2026-05-15	Quarterly report (2026.03)	DART
2026-05-12	Material management matter	DART
2026-05-07	Material management matter	DART
2026-04-30	Material management matter	DART
2026-04-10	Material management matter	DART
2026-03-26	Annual general meeting results	DART
2026-03-26	Change in shareholdings of largest shareholder	DART
2026-03-23	Audit report submitted	DART

Showing the 20 most recent of 47 filings. The full brief lists all of them.

Full brief on DAEWOONG CO.,LTD — $39

Every filing from the last 12 months in English, not just the 20 most recent — each linked to its Korean original
Latest half-year and quarterly figures on top of the three annual years, plus the full auditor and largest-shareholder history
Any KOSPI, KOSDAQ or KONEX company, not just the ones listed here — delivered as a private link the moment payment clears

Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

AHN-GOOK PHARMACEUTICAL Co., Ltd. KOSDAQ 001540
Aprogen Biologics Inc. KOSPI 003060
Aprogen, Inc KOSPI 007460
Boryung Corporation KOSPI 003850
BUKWANG PHARMACEUTICAL IND CO.,LTD KOSPI 003000
CHONGKUNDANG HOLDINGS CORP. KOSPI 001630

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.